Investment management team update

RNS Number : 3688T
BB Healthcare Trust PLC
20 March 2019
 

20 March 2019

BB Healthcare Trust plc

 

Investment management team update

 

The Board of BB Healthcare Trust plc (the "Trust" or "BB Healthcare") today announces an update to the Trust's investment management team at Bellevue Asset Management AG ("Bellevue"). Bellevue has informed the Board that Dr Daniel Koller will step back from his role within the Trust's investment management team to focus on BB Biotech AG ("BB Biotech").

 

BB Healthcare will continue to be advised by its Investment Advisory Team of Paul Major and Brett Darke based in London. It was always expected that Dr Koller would step back as the Trust evolved, and Bellevue has confirmed that it will continue to provide in depth support to the Trust and fulfil its obligations under the delegated portfolio management agreement. BB Biotech and BB Healthcare Trust will continue to co-operate closely with their in-depth bottom-up stock selection and analytical processes.

 

Justin Stebbing, Chairman, commented: "The Board would like to thank Daniel for his support of Paul and Brett during the early years of this project, and we wish him continued success in the future. BB Healthcare's Investment Team has delivered strong results for investors in these early years and the Board has every confidence that they will continue to deliver moving forward."

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014.

 

The Company's LEI is: 213800HQ3J3H9YF2UI82

 

For further information please contact:

 

Bellevue Advisors Limited

 

Paul Major

+44 (0)20 3326 2982

Brett Darke

+44 (0)20 3871 2862

Claude Mikkelsen

+44 (0)755 704 8577

 

 

Peel Hunt LLP

+44 (0)20 7418 8900

Liz Yong, Helen Rennardson (Corporate Broking)

 

Mark Thompson, Chris Bunstead (Sales)

 

 

 

J.P. Morgan Cazenove

+44 (0)20 7742 4000

William Simmonds

 

Ed Murray

 

Eddie Nissen (Sales)

 

Oliver Kenyon

 

 

 

Maitland/amo - Financial PR

+44 (0)20 7379 5151

William Clutterbuck

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKCDPKBKBPND
UK 100

Latest directors dealings